Allyx Therapeutics Alternatives & Competitors
12 companies similar to Allyx Therapeutics — Protecting Synapses and Reversing Neurodegeneration
Companies similar to Allyx Therapeutics
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
San Diego, United States
Gismo Therapeutics Inc.
Pioneering advanced treatments for Alzheimer’s and Parkinson’s diseases since 2013.
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
Cambridge, United Kingdom
Track all Allyx Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
XWPharma
Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other unders...
United States
Vantage Biosciences
Transforming diabetic eye disease with an oral treatment
London, United Kingdom
Therini Bio, Inc.
A new approach to block vascular-mediated inflammation
Sacramento, United States
Tenaya Therapeutics
Scaling new heights in the fight against heart disease
South San Francisco, Unit...
Resalis Therapeutics
Tackling metabolic disorders with non-coding RNAs
Turin, Italy
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
United States
Bionomics Ltd
Developing novel drug candidates to transform the lives of patients with anxiety and stres...
Australia
ESCAPE Bio
A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEUROD...
South San Francisco, Unit...
About Allyx Therapeutics
Allyx Therapeutics is a clinical stage biotechnology company founded in 2018 with the mission to develop disease modifying therapies for Alzheimer's and Parkinson's disease. The company's slogan, "Protecting Synapses and Reversing Neurodegeneration," reflects its focus on targeting the underlying cause of synapse dysfu...
Allyx Therapeutics, Clinical Stage, Neurodegeneration, Alzheimer's Disease, Parkinson's Disease, Disease Modifying Therapies, Synapse Dysfunction, Small Molecule, Oral Drug, Cognition Preservation, Neurological Disorders, Clinical Trials, Drug Development
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Allyx Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Allyx Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
